Asahi Pharma Call for EU Researchers proposals
Deadline: 23 December, 2017 (All day)
Asahi Kasei Pharma call for applications (research grant 50000 $) / target: EU researchers
Asahi Kasei Pharma is looking for partnerships with European technology counterparts.
This is an open competition, and the objective is to target new potential areas for growth and mutual benefits.
Asahi Kasei Pharma believes “locomotive syndrome” to be a serious problem that needs to be urgently addressed in our aging society.
For this reason, the company dedicates their research and development efforts toward developing new drugs that help patients worldwide who are suffering from chronic pain, metabolic bone diseases, or rheumatoid arthritis. The company is a leader in the field of these disorders and have thus far developed the synthetic calcitonin derivative Elcitonin®, the human parathyroid hormone preparation Teribone®, and the immunosuppressant Bredinin®.